[Recurrent lepromatous leprosy in conventional triple therapy: value of the rifampicin-ofloxacin combination].
Marlier
S
S
Carsuzaa
F
F
De Jaureguiberry
J P
JP
Galzin
M
M
Carloz
E
E
Carli
P
P
Chagnon
A
A
D000368:Aged; D004359:Drug Therapy, Combination; D006801:Humans; D007917:Leprostatic Agents / Q000627:therapeutic use*; D015440:Leprosy, Lepromatous / Q000188:drug therapy*; D008297:Male; D015242:Ofloxacin / Q000627:therapeutic use*; D012008:Recurrence; D012293:Rifampin / Q000627:therapeutic use*
D007917:Leprostatic Agents; D015242:Ofloxacin; D012293:Rifampin
Lepre lepromateuse recidivante sous tritherapie conventionnelle: interet de l'association rifampicine-ofloxacine.